Skip to content
DilutionScan

Lockup agreement

A lockup agreement is a promise by insiders or investors not to sell or transfer their shares for a set period, commonly 90 to 180 days after an IPO or an offering.

Last verified

How it works

Underwriters and placement agents typically require officers, directors and large holders to sign lockups before an offering. Each signer agrees not to sell, pledge or otherwise transfer shares (and often not to hedge them) for a fixed period. For IPOs the period is commonly 180 days; for follow-on and registered direct offerings it is often shorter, such as 60 or 90 days. The company itself frequently agrees to a standstill on new issuances for a period too.

Lockups can include early release provisions, for example after a strong earnings release, or if the stock trades above a set price for a number of days. The underwriter can also waive a lockup.

Why it matters

A lockup temporarily removes shares from the supply that can trade. When it expires, a large number of shares can become saleable on a single date. In companies with a small public float, the shares held by insiders and pre-IPO investors can be several times the float.

Worked example

Hypothetical: Company X lists with 3,000,000 shares sold in its IPO and 17,000,000 held by founders and pre-IPO investors under 180-day lockups. On day 181, up to 17,000,000 more shares can be sold, subject to Rule 144 for affiliates and any restricted shares. That is more than five times the IPO share count.

How to spot it

The IPO prospectus (S-1 and the final 424B4) has a section titled "Shares Eligible for Future Sale" and an "Underwriting" section describing lockups. Follow-on prospectus supplements and purchase agreements describe the company's own standstill. See Lockup expirations.

Guides that use this term

Check any ticker for dilution

DilutionScan reads each covered company's SEC filings and lists its warrants, convertibles, ATM programs, shelves and S-1s on one page, with a dilution rating and cash runway.

Definition from the Signal8 Academy glossary. Educational content only. DilutionScan and Signal8 are not broker-dealers or investment advisers, and nothing here is a recommendation to buy or sell any security.

DilutionScan ProEvery instrument in full · $59/mo